News & Perspective

Dec 31, 2008

Dec 31, 2008

Study hints at pneumonia risk with resistant flu viruses

(CIDRAP News) – A newly published analysis of oseltamivir-resistant influenza viruses collected last winter in Norway hints that they may increase an infected person's risk of pneumonia and sinus infections, but the small number of patients in the study means the finding is no more than a hint at this point.

Dec 19, 2008

Dec 19, 2008

With H1N1 resistance, CDC changes advice on flu drugs

(CIDRAP News) – Increased resistance to oseltamivir (Tamiflu), the leading influenza drug, has prompted federal health officials to change their advice about flu treatment, saying clinicians for now should consider using zanamivir (Relenza) or a combination of two drugs for patients suspected of having influenza A.

Dec 12, 2008

Dec 12, 2008

CDC sees early-season signs of Tamiflu resistance

(CIDRAP News) – With this year's US influenza epidemic barely getting started, there are already signs of increased viral resistance to oseltamivir (Tamiflu), the most widely used antiviral drug, the Centers for Disease Control and Prevention (CDC) said today.

In its flu surveillance report for Nov 30 to Dec 6, released today, the CDC said 45 of 46 influenza A/H1N1 viruses tested so far have shown resistance to oseltamivir.

Oct 27, 2008

Oct 27, 2008

Drug-resistant flu viruses cause growing concern

– WASHINGTON, DC (CIDRAP News) – Health officials worldwide are becoming increasingly concerned about influenza viruses' resistance to antiviral drugs, which can shut down a flu infection or mitigate symptoms. Flu antivirals are vital for reducing severe illness and death in average flu seasons and could be essential bulwarks against an influenza pandemic if one began.

Sep 05, 2008

Sep 05, 2008

Dutch patient dies from Tamiflu-resistant H1N1 virus

(CIDRAP News) – Amid concern about rising resistance to oseltamivir (Tamiflu) in influenza A/H1N1 viruses, a Dutch team this week reported the death of a leukemia patient who was infected with an H1N1 virus that was resistant to the antiviral drug.

May 06, 2008

May 06, 2008

Pew report urges limiting antimicrobial use in animals

(CIDRAP News) – After a 2-year study of the effects of large-scale farm animal production, a panel of experts has called for phasing out the nontherapeutic use of antimicrobials in farm animals in order to maintain the effectiveness of antibiotics in humans.

Feb 07, 2008

Feb 07, 2008

Europe reports further increase in Tamiflu resistance

(CIDRAP News) – European health officials today reported signs of an increasing rate of resistance to oseltamivir (Tamiflu) in Europe's predominant subtype of influenza virus, but they cautioned that the rate seen in isolates tested so far may not reflect the real situation.

Feb 01, 2008

Feb 01, 2008

Europe says Tamiflu-resistant virus seen in 9 countries

(CIDRAP News) – European officials yesterday reported more evidence that one of the three types of seasonal influenza viruses is showing resistance to oseltamivir (Tamiflu) and said this represents the first clear sign that the resistant variant can spread.

Jan 29, 2008

Jan 29, 2008

Europeans find Tamiflu resistance in seasonal flu virus

(CIDRAP News) – An early report on the seasonal influenza strains circulating in Europe reveals that some H1N1 viruses show signs of resistance to the antiviral drug oseltamivir, the European Centre for Disease Prevention and Control (ECDC) reported this week.

Jan 02, 2008

Jan 02, 2008

Air trip by drug-resistant TB patient prompts passenger testing

(CIDRAP News) – Federal health officials recently issued an alert about a woman with multidrug-resistant tuberculosis (MDR TB) who flew from India to the United States in mid December, and efforts are under way to locate and test several of her fellow passengers for the disease.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»